Author:
Zhang Chi,Zhang Peizhe,Li Hongxia,Han Lianhua,Zhang Lei,Zhang Lei,Yang Xiangjun
Reference30 articles.
1. Dabigatran etexilate–a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity;van Ryn;Thromb. Haemost.,2010
2. Direct thrombin inhibitors;Di Nisio;N. Engl. J. Med.,2005
3. Direct oral anticoagulants–pharmacology, drug interactions, and side effects;Dempfle;Semin. Hematol.,2014
4. Pharmacokinetics and pharmacodynamics of dabigatran 75 mg b.i.d. in patients with severe chronic kidney disease;Kooiman;J. Am. Coll. Cardiol.,2016
5. The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects;Stangier;Br. J. Clin. Pharmacol.,2007
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献